YUMANITY THERAPEUTICS INC (YMTX) Stock Analyst Ratings
USA - NASDAQ:YMTX - US98872L1026 - Common Stock
1.89 USD
+0.15 (+8.62%)
1.9 USD
+0.01 (+0.53%)
ChartMill assigns a Buy % Consensus number of 84% to YMTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 35.7. This target is 1788.89% above the current price.
YMTX was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about YMTX.
In the previous month the buy percentage consensus was at a similar level.
YMTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-06-04 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-01 | Jefferies | Initiate | Buy |
YUMANITY THERAPEUTICS INC / YMTX FAQ
What is the price target for YMTX stock?
9 analysts have analysed YMTX and the average price target is 35.7 USD. This implies a price increase of 1788.89% is expected in the next year compared to the current price of 1.89.
What is the consensus rating for YUMANITY THERAPEUTICS INC (YMTX) stock?
The consensus rating for YUMANITY THERAPEUTICS INC (YMTX) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed YUMANITY THERAPEUTICS INC (YMTX)?
The number of analysts covering YUMANITY THERAPEUTICS INC (YMTX) is 9.